Report Overview
The global Intranasal Vaccine market was valued at 568 million in 2024 and is projected to reach US$ 814 million by 2031, at a CAGR of 5.4% during the forecast period.
Vaccines administered nasally
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Prospect Research Reports (PRR) has surveyed the Intranasal Vaccine manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Intranasal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Vaccine. This report contains market size and forecasts of Intranasal Vaccine in global, including the following market information:
Global Intranasal Vaccine market revenue, 2020-2025, 2026-2031, ($ millions)
Global Intranasal Vaccine market sales, 2020-2025, 2026-2031, (K Units)
Global top five Intranasal Vaccine companies in 2024 (%)
Total Market by Segment:
Global Intranasal Vaccine market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Intranasal Vaccine market segment percentages, by Type, 2024 (%)
Flu Vaccine
COVID-19 Vaccines
Global Intranasal Vaccine market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Intranasal Vaccine market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Global Intranasal Vaccine market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Intranasal Vaccine market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intranasal Vaccine revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Intranasal Vaccine revenues share in global market, 2024 (%)
Key companies Intranasal Vaccine sales in global market, 2020-2025 (estimated), (K Units)
Key companies Intranasal Vaccine sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
AstraZeneca
Abbott
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
BioDiem
PharmaJet and Crossject
Beijing Wantai Biopharmaceutical Co., Ltd.
Changchun Baike Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intranasal Vaccine, market overview.
Chapter 2: Global Intranasal Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Intranasal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intranasal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intranasal Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
